These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33298616)

  • 1. AdrA as a Potential Immunomodulatory Candidate for STING-Mediated Antiviral Therapy That Required Both Type I IFN and TNF-α Production.
    Rodriguez-Garcia E; Zabaleta N; Gil-Farina I; Gonzalez-Aparicio M; Echeverz M; Bähre H; Solano C; Lasa I; Gonzalez-Aseguinolaza G; Hommel M
    J Immunol; 2021 Jan; 206(2):376-385. PubMed ID: 33298616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diminished Innate Antiviral Response to Adenovirus Vectors in cGAS/STING-Deficient Mice Minimally Impacts Adaptive Immunity.
    Anghelina D; Lam E; Falck-Pedersen E
    J Virol; 2016 Jul; 90(13):5915-27. PubMed ID: 27076643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MPYS/STING-mediated TNF-α, not type I IFN, is essential for the mucosal adjuvant activity of (3'-5')-cyclic-di-guanosine-monophosphate in vivo.
    Blaauboer SM; Gabrielle VD; Jin L
    J Immunol; 2014 Jan; 192(1):492-502. PubMed ID: 24307739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Telomerase-Derived Peptide Exerts an Anti-Hepatitis B Virus Effect
    Choi YM; Kim H; Lee SA; Lee SY; Kim BJ
    Front Immunol; 2020; 11():652. PubMed ID: 32508804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe combined immunodeficiency in stimulator of interferon genes (STING) V154M/wild-type mice.
    Bouis D; Kirstetter P; Arbogast F; Lamon D; Delgado V; Jung S; Ebel C; Jacobs H; Knapp AM; Jeremiah N; Belot A; Martin T; Crow YJ; André-Schmutz I; Korganow AS; Rieux-Laucat F; Soulas-Sprauel P
    J Allergy Clin Immunol; 2019 Feb; 143(2):712-725.e5. PubMed ID: 29800647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction.
    Suárez-Amarán L; Usai C; Di Scala M; Godoy C; Ni Y; Hommel M; Palomo L; Segura V; Olagüe C; Vales A; Ruiz-Ripa A; Buti M; Salido E; Prieto J; Urban S; Rodríguez-Frias F; Aldabe R; González-Aseguinolaza G
    J Hepatol; 2017 Oct; 67(4):669-679. PubMed ID: 28527664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral activity and hepatoprotection by heme oxygenase-1 in hepatitis B virus infection.
    Protzer U; Seyfried S; Quasdorff M; Sass G; Svorcova M; Webb D; Bohne F; Hösel M; Schirmacher P; Tiegs G
    Gastroenterology; 2007 Oct; 133(4):1156-65. PubMed ID: 17919491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of hepatitis B virus to impede the replication of HBV in vitro and in vivo.
    Leong CR; Funami K; Oshiumi H; Mengao D; Takaki H; Matsumoto M; Aly HH; Watashi K; Chayama K; Seya T
    Oncotarget; 2016 Oct; 7(42):68179-68193. PubMed ID: 27626689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMP-activated Kinase (AMPK) Promotes Innate Immunity and Antiviral Defense through Modulation of Stimulator of Interferon Genes (STING) Signaling.
    Prantner D; Perkins DJ; Vogel SN
    J Biol Chem; 2017 Jan; 292(1):292-304. PubMed ID: 27879319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and application of hepatitis B virus persistent replication model in IFNAR(-/-) mouse.
    Chen MF; Lin Y; Xia YC; Sun C; Feng XM; Lu MJ; Yang DL; Wu J
    J Huazhong Univ Sci Technolog Med Sci; 2013 Jun; 33(3):392-397. PubMed ID: 23771666
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Costa Franco MM; Marim F; Guimarães ES; Assis NRG; Cerqueira DM; Alves-Silva J; Harms J; Splitter G; Smith J; Kanneganti TD; de Queiroz NMGP; Gutman D; Barber GN; Oliveira SC
    J Immunol; 2018 Jan; 200(2):607-622. PubMed ID: 29203515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells.
    Takaki H; Honda K; Atarashi K; Kobayashi F; Ebihara T; Oshiumi H; Matsumoto M; Shingai M; Seya T
    Mol Immunol; 2014 Feb; 57(2):100-10. PubMed ID: 24096085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector.
    Hensley SE; Cun AS; Giles-Davis W; Li Y; Xiang Z; Lasaro MO; Williams BR; Silverman RH; Ertl HC
    Mol Ther; 2007 Feb; 15(2):393-403. PubMed ID: 17235319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathways.
    Liu Y; Li J; Chen J; Li Y; Wang W; Du X; Song W; Zhang W; Lin L; Yuan Z
    J Virol; 2015 Feb; 89(4):2287-300. PubMed ID: 25505063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of type I interferon signaling in human metapneumovirus pathogenesis and control of viral replication.
    Hastings AK; Erickson JJ; Schuster JE; Boyd KL; Tollefson SJ; Johnson M; Gilchuk P; Joyce S; Williams JV
    J Virol; 2015 Apr; 89(8):4405-20. PubMed ID: 25653440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING.
    Rueckert C; Rand U; Roy U; Kasmapour B; Strowig T; Guzmán CA
    FASEB J; 2017 Jul; 31(7):3107-3115. PubMed ID: 28396343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal Ablation of Alpha/Beta Interferon (IFN-α/β) Signaling Exacerbates Central Nervous System Viral Dissemination and Impairs IFN-γ Responsiveness in Microglia/Macrophages.
    Hwang M; Bergmann CC
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32796063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient Induction of Cytotoxic T Cells by Viral Vector Vaccination Requires STING-Dependent DC Functions.
    Barnowski C; Ciupka G; Tao R; Jin L; Busch DH; Tao S; Drexler I
    Front Immunol; 2020; 11():1458. PubMed ID: 32765505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Stimulator of Interferon Genes in Hepatocytes Suppresses the Replication of Hepatitis B Virus.
    Guo F; Tang L; Shu S; Sehgal M; Sheraz M; Liu B; Zhao Q; Cheng J; Zhao X; Zhou T; Chang J; Guo JT
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28717041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vivo Conditions Enable IFNAR-Independent Type I Interferon Production by Peritoneal CD11b+ Cells upon Thogoto Virus Infection.
    Kochs G; Anzaghe M; Kronhart S; Wagner V; Gogesch P; Scheu S; Lienenklaus S; Waibler Z
    J Virol; 2016 Oct; 90(20):9330-7. PubMed ID: 27512061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.